-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, TLSc6PLyS70eHCNVJRvNDPZIHwJEmTlv/6GqJklMHrzHm/bkhd8Jc27eAPsS5XIj usmKCCzZXomVwDqznAfvtA== 0000950138-10-000596.txt : 20101004 0000950138-10-000596.hdr.sgml : 20101004 20101004170357 ACCESSION NUMBER: 0000950138-10-000596 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080610 FILED AS OF DATE: 20101004 DATE AS OF CHANGE: 20101004 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PYXIS INNOVATIONS INC CENTRAL INDEX KEY: 0001221575 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-32715 FILM NUMBER: 101106453 BUSINESS ADDRESS: STREET 1: 7575 FULTON STREET EAST CITY: ADA STATE: MI ZIP: 49355-0001 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INTERLEUKIN GENETICS INC CENTRAL INDEX KEY: 0001037649 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 943123681 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 135 BEAVER ST CITY: WATHAM STATE: MA ZIP: 02452 BUSINESS PHONE: 1-781-398-0700 MAIL ADDRESS: STREET 1: 135 BEAVER ST CITY: WATHAM STATE: MA ZIP: 02452 FORMER COMPANY: FORMER CONFORMED NAME: MEDICAL SCIENCE SYSTEMS INC DATE OF NAME CHANGE: 19971003 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ALTICOR INC CENTRAL INDEX KEY: 0000941980 STATE OF INCORPORATION: MI FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-32715 FILM NUMBER: 101106450 BUSINESS ADDRESS: STREET 1: 7575 FULTON ST CITY: ADA STATE: MI ZIP: 49355-7410 BUSINESS PHONE: 6167876928 MAIL ADDRESS: STREET 1: 7575 FULTON ST CITY: ADA STATE: MI ZIP: 49355-7410 FORMER NAME: FORMER CONFORMED NAME: AMWAY CORP DATE OF NAME CHANGE: 19990115 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SOLSTICE HOLDINGS INC CENTRAL INDEX KEY: 0001257877 STATE OF INCORPORATION: MI FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-32715 FILM NUMBER: 101106451 BUSINESS ADDRESS: STREET 1: 7575 FULTON STREET EAST CITY: ADA STATE: MI ZIP: 49355 BUSINESS PHONE: 6167877263 MAIL ADDRESS: STREET 1: 7575 FULTON STREET EAST CITY: ADA STATE: MI ZIP: 49355 FORMER NAME: FORMER CONFORMED NAME: ALTICOR HOLDINGS INC DATE OF NAME CHANGE: 20030801 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Alticor Global Holdings Inc. CENTRAL INDEX KEY: 0001303680 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-32715 FILM NUMBER: 101106452 BUSINESS ADDRESS: STREET 1: 7575 FULTON STREET EAST CITY: ADA STATE: MI ZIP: 49355-0001 BUSINESS PHONE: (616) 787-5221 MAIL ADDRESS: STREET 1: 7575 FULTON STREET EAST CITY: ADA STATE: MI ZIP: 49355-0001 4/A 1 edgar.xml PRIMARY DOCUMENT X0303 4/A 2008-06-10 2008-06-13 0001037649 INTERLEUKIN GENETICS INC ILI 0001221575 PYXIS INNOVATIONS INC 7575 FULTON STREET EAST ADA MI 49355-0001 0 0 1 0 0001303680 Alticor Global Holdings Inc. 7575 FULTON STREET EAST ADA MI 49355-0001 0 0 1 0 0001257877 SOLSTICE HOLDINGS INC 7575 FULTON STREET EAST ADA MI 49355-0001 0 0 1 0 0000941980 ALTICOR INC 7575 FULTON STREET EAST ADA MI 49355-0001 0 0 1 0 Convertible Promissory Note 5.6783 2008-06-10 4 P 0 4000000.00 A Common Stock 704437 28864637 D Convertible Promissory Note 5.6783 2009-05-29 4 P 0 1000000.00 A Common Stock 176110 29040747 D Convertible Promissory Note 5.6783 2009-11-09 4 P 0 2000000.00 A Common Stock 352219 29392966 D Convertible Promissory Note 5.6783 2010-02-01 4 P 0 2000000.00 A Common Stock 352219 29745185 D Convertible Promissory Note 5.6783 2010-09-30 4 P 0 2000000.00 A Common Stock 352219 30097404 D On June 10, 2008, Pyxis was issued a convertible promissory note by the Issuer with an original principal amount of $4,000,000. On September 30, 2010, this convertible promissory note was amended and restated to extend the maturity date on which the principal amount of the convertible promissory note will be payable to June 30, 2012. The original principal amount of the convertible promissory note, plus accrued interest thereon, is convertible into the Issuer's common stock at any time at the option of Pyxis. The maximum number of shares of common stock into which the balance of this convertible promissory note may be converted is determined by dividing the aggregate principal amount to be converted, together with all accrued interest to the date of conversion, by $5.6783. As of June 10, 2008, the convertible promissory note would have been convertible into 704,437 shares of the Issuer's common stock. On May 29, 2009, Pyxis was issued a convertible promissory note by the Issuer with an original principal amount of $1,000,000. On September 30, 2010, this convertible promissory note was amended and restated to extend the maturity date on which the principal amount of the convertible promissory note will be payable to June 30, 2012. The original principal amount of the convertible promissory note, plus accrued interest thereon, is convertible into the Issuer's common stock at any time at the option of Pyxis. The maximum number of shares of common stock into which the balance of this convertible promissory note may be converted is determined by dividing the aggregate principal amount to be converted, together with all accrued interest to the date of conversion, by $5.6783. As of May 29, 2009, the convertible promissory note would have been convertible into 176,110 shares of the Issuer's common stock. On November 9, 2009, Pyxis was issued a convertible promissory note by the Issuer with an original principal amount of $2,000,000. On September 30, 2010, this convertible promissory note was amended and restated to extend the maturity date on which the principal amount of the convertible promissory note will be payable to June 30, 2012. The original principal amount of the convertible promissory note, plus accrued interest thereon, is convertible into the Issuer's common stock at any time at the option of Pyxis. The maximum number of shares of common stock into which the balance of this convertible promissory note may be converted is determined by dividing the aggregate principal amount to be converted, together with all accrued interest to the date of conversion, by $5.6783. As of November 9, 2009, the convertible promissory note would have been convertible into 352,219 shares of the Issuer's common stock. On February 1, 2010, Pyxis was issued a convertible promissory note by the Issuer with an original principal amount of $2,000,000. On September 30, 2010, this convertible promissory note was amended and restated to extend the maturity date on which the principal amount of the convertible promissory note will be payable to June 30, 2012. The original principal amount of the convertible promissory note, plus accrued interest thereon, is convertible into the Issuer's common stock at any time at the option of Pyxis. The maximum number of shares of common stock into which the balance of this convertible promissory note may be converted is determined by dividing the aggregate principal amount to be converted, together with all accrued interest to the date of conversion, by $5.6783. As of February 1, 2010, the convertible promissory note would have been convertible into 352,219 shares of the Issuer's common stock. On September 30, 2010, Pyxis was issued a convertible promissory note by the Issuer with an original principal amount of $2,000,000. The maturity date of this convertible promissory note is June 30, 2012. The original principal amount of the convertible promissory note, plus accrued interest thereon, is convertible into the Issuer's common stock at any time at the option of Pyxis. The maximum number of shares of common stock into which the balance of this convertible promissory note may be converted is determined by dividing the aggregate principal amount to be converted, together with all accrued interest to the date of conversion, by $5.6783. As of September 30, 2010, the convertible promissory note would have been convertible into 352,219 shares of the Issuer's common stock. This amount includes 5,000,000 shares of the Issuer's Series A preferred stock held by Pyxis, which are convertible into 28,160,200 shares of common stock. As of September 30, 2010, Pyxis holds five convertible promissory notes issued by the Issuer in the aggregate principal amount of $11,000,000. Taking into account accrued interest as of September 30, 2010, these notes are currently convertible into a maximum of 1,946,044 shares of common stock of Pyxis. As of September 30, 2010, Pyxis is the holder of preferred stock and notes (including accrued interest) convertible into an aggregate of 30,106,244 shares of common stock. /s/ Kim S. Mitchell, Assistant Secretary 2010-10-04 ALTICOR GLOBAL HOLDINGS INC., /s/ Kim S. Mitchell, Assistant Secretary 2010-10-04 SOLSTICE HOLDINGS INC., /s/ Kim S. Mitchell, Assistant Secretary 2010-10-04 ALTICOR INC., /s/ Kim S. Mitchell, Assistant Secretary 2010-10-04 -----END PRIVACY-ENHANCED MESSAGE-----